Unknown

Dataset Information

0

Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation.


ABSTRACT: Second-generation (Gen 2) Antisense oligonucleotides (ASOs) show increased nuclease stability and affinity for their RNA targets, which has translated to improved potency and therapeutic index in the clinic. Gen 2 ASOs are typically modified using the phosphorothioate (PS) backbone modification, which enhances ASO interactions with plasma, cell surface, and intracellular proteins. This facilitates ASO distribution to peripheral tissues and also promotes cellular uptake after injection into animals. Previous work identified that Stabilin receptors specifically internalize PS-ASOs in the sinusoidal endothelial cells of the liver and the spleen. By modulating expression of specific proteins involved in the trafficking and maturation of the endolysosomal compartments, we show that Rab5C and EEA1 in the early endosomal pathway, and Rab7A and lysobisphosphatidic acid in the late endosomal pathway, are important for trafficking of PS-ASOs and facilitate their escape from endolysosomal compartments after Stabilin-mediated internalization. In conclusion, this work identifies key rate-limiting proteins in the pathway for PS-ASO translocation and escape from the endosome.

SUBMITTER: Miller CM 

PROVIDER: S-EPMC5899299 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation.

Miller Colton M CM   Wan W Brad WB   Seth Punit P PP   Harris Edward N EN  

Nucleic acid therapeutics 20180213 2


Second-generation (Gen 2) Antisense oligonucleotides (ASOs) show increased nuclease stability and affinity for their RNA targets, which has translated to improved potency and therapeutic index in the clinic. Gen 2 ASOs are typically modified using the phosphorothioate (PS) backbone modification, which enhances ASO interactions with plasma, cell surface, and intracellular proteins. This facilitates ASO distribution to peripheral tissues and also promotes cellular uptake after injection into anima  ...[more]

Similar Datasets

| S-EPMC4824115 | biostudies-literature
| S-EPMC10393622 | biostudies-literature
| S-EPMC5605259 | biostudies-literature
| S-EPMC10899043 | biostudies-literature
| S-EPMC5971383 | biostudies-literature
| S-EPMC10129852 | biostudies-literature
| S-EPMC10635116 | biostudies-literature
| S-EPMC1220083 | biostudies-other
| S-EPMC8450106 | biostudies-literature
| S-EPMC10153260 | biostudies-literature